Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: erlotinib hydrochloride|GENETIC: TUNEL assay|GENETIC: protein expression analysis|OTHER: immunohistochemistry staining method|OTHER: laboratory biomarker analysis|OTHER: liquid chromatography|OTHER: mass spectrometry|OTHER: matrix-assisted laser desorption ionization mass spectrometry|PROCEDURE: therapeutic conventional surgery
Sponsor: Vanderbilt-Ingram Cancer Center
Collaborators: National Cancer Institute (NCI)